Cargando…

Radiological insertion of automated low flow ascitic pump (alfapump(®)) system for management of medically refractory ascites

Ascites is well-documented sequelae of liver cirrhosis with significant impact on survival in this group of patients. Among the many established management strategies for the same is the use of an implantable mechanical device, called alfapump(®) (Sequana Medical, Zurich, Switzerland), that removes...

Descripción completa

Detalles Bibliográficos
Autores principales: Karkhanis, Salil, Jones, Robert, Willis, Andrew, Mccarthy, Eoghan, Zia, Zergham, Mehrzad, Homoyoon, O'rourke, Joanne, Holt, Andrew, Tripathi, Dhiraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Institute of Radiology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159181/
https://www.ncbi.nlm.nih.gov/pubmed/30363221
http://dx.doi.org/10.1259/bjrcr.20170025
Descripción
Sumario:Ascites is well-documented sequelae of liver cirrhosis with significant impact on survival in this group of patients. Among the many established management strategies for the same is the use of an implantable mechanical device, called alfapump(®) (Sequana Medical, Zurich, Switzerland), that removes ascitic fluid by pumping it from the peritoneal cavity to the urinary bladder. Until recently, this device has been surgically placed under general anaesthesia. We describe successful interventional radiological implantation under conscious sedation in three patients with minimal complications. This device can serve as an alternative to transjugular intrahepatic portosystemic shunt for the management of refractory ascites; however, further studies are required to understand the device better.